Skip to main content
SpringerLink
Log in

Radiation-Induced Liver Disease

  • Chapter
  • First Online:
Acute Side Effects of Radiation Therapy

  • 2062 Accesses

Abstract

Radiation-induced liver disease (RILD), historically called radiation hepatitis, has been reported in 6–66% of patients whose livers are irradiated based on radiation dose, exposed liver volume, and baseline liver function [1, 2]. Abnormalities in laboratory liver function tests may be found on routine evaluation of patients when RILD is mild, but in severe cases, liver dysfunction may affect the treatment course and eventually threaten patient’s lives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Munden RF, Erasmus JJ, Smythe WR, Madewell JE, Forster KM, Stevens CW (2005) Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: an unusual CT appearance. Am J Roentgenol 184(4):1091–1095

    Article  Google Scholar 

  2. Khozouz RF, Huq SZ, Perry MC (2008) Radiation-induced liver disease. J Clin Oncol 26(29):4844–4845

    Article  PubMed  Google Scholar 

  3. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31(5):1237–1248

    Article  CAS  PubMed  Google Scholar 

  4. Sempoux C, Horsmans Y, Geubel A, Fraikin J, Van Beers BE, Gigot JF, Lerut J, Rahier J (1997) Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: activation of hepatic stellate cells as an early event. Hepatology 26(1):128–134

    Article  CAS  PubMed  Google Scholar 

  5. Wang S, Lee Y, Kim J, Hyun J, Lee K, Kim Y, Jung Y (2013) Potential role of Hedgehog pathway in liver response to radiation. PLoS One 8(9):e74141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Olsen CC, Welsh J, Kavanagh BD, Franklin W, McCarter M, Cardenes HR, Gaspar LE, Schefter TE (2009) Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 73(5):1414–1424

    Article  CAS  PubMed  Google Scholar 

  7. Cheng W, Xiao L, Ainiwaer A, Wang Y, Wu G, Mao R, Yang Y, Bao Y (2015) Molecular responses of radiation-induced liver damage in rats. Mol Med Rep 11(4):2592–2600

    CAS  PubMed  Google Scholar 

  8. Reed GB Jr, Cox AJ Jr (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48(4):597–611

    PubMed  PubMed Central  Google Scholar 

  9. Cheng JC, JK W, Lee PC, Liu HS, Jian JJ, Lin YM, Sung JL, Jan GJ (2004) Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 60:1502–1509

    Article  PubMed  Google Scholar 

  10. Lawrence TS, Ten Haken RK, Kessler ML, Robertson JM, Lyman JT, Lavigne ML, Brown MB, DuRoss DJ, Andrews JC, Ensminger WD et al (1992) The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23(4):781–788

    Article  CAS  PubMed  Google Scholar 

  11. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122

    Article  CAS  PubMed  Google Scholar 

  12. Liang SX, Zhu XD, ZY X, Zhu J, Zhao JD, HJ L, Yang YL, Chen L, Wang AY, XL F, Jiang GL (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65(2):426–434

    Article  PubMed  Google Scholar 

  13. Haddad E, Le Bourgeois JP, Kuentz M, Lobo P (1983) Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: preliminary results. Int J Radiat Oncol Biol Phys 9(9):1313–1319

    Article  CAS  PubMed  Google Scholar 

  14. McCracken JD, Weatherall TJ, Oishi N, Janaki L, Boyer C (1985) Adjuvant intrahepatic chemotherapy with mitomycin and 5-FU combined with hepatic irradiation in high-risk patients with carcinoma of the colon: a Southwest Oncology Group phase II pilot study. Cancer Treat Rep 69(1):129–131

    CAS  PubMed  Google Scholar 

  15. Byfield JE, Barone RM, Frankel SS, Sharp TR (1984) Treatment with combined intra-arterial 5-FUdR infusion and whole-liver radiation for colon carcinoma metastatic to the liver. Preliminary results. Am J Clin Oncol 7(4):319–325

    Article  CAS  PubMed  Google Scholar 

  16. Friedman M, Cassidy M, Levine M, Phillips T, Spivack S, Resser KJ (1979) Combined modality therapy of hepatic metastasis. Cancer 44:906–913

    Article  CAS  PubMed  Google Scholar 

  17. Lokich J, Kinsella T, Perri J, Malcolm A, Clouse M (1981) Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: correlation of liver scan, liver function tests, and plasma CEA with tumor response. Cancer 48(12):2569–2574

    Article  CAS  PubMed  Google Scholar 

  18. Yin H, Lu K, Qiao W-B, Zhang H-Y, Sun D, You Q-S (2014) Whole-liver radiotherapy concurrent with chemotherapy as a palliative treatment for colorectal patients with massive and multiple liver metastases: a retrospective study. Asian Pac J Cancer Prev 15(4):1597–1602

    Article  PubMed  Google Scholar 

  19. Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, Ten Haken RK (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S94–100

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tomé WA, Fenwick JD (2004) Analysis of radiation-induced liver disease using the Lyman NTCP model: in regard to Dawson et al. IJROBP 2002;53:810-821. Int J Radiat Oncol Biol Phys 58(4):1318–1319

    Article  PubMed  Google Scholar 

  21. Seong J, Park HC, Han KH, Chon CY (2003) Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55(2):329–336

    Article  PubMed  Google Scholar 

  22. Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53(4):810–821

    Article  PubMed  Google Scholar 

  23. Lightdale CJ, Wasser J, Coleman M, Brower M, Tefft M, Pasmantier M (1979) Anticoagulation and high dose liver radiation: a preliminary report. Cancer 43(1):174–181

    Article  CAS  PubMed  Google Scholar 

  24. Tefft M, Mitus A, Das L, Vawter GF, Filler RM (1970) Irradiation of the liver in children: review of experience in the acute and chronic phases, and in the intact normal and partially resected. Am J Roentgenol Radium Ther Nucl Med 108(2):365–385

    Article  CAS  PubMed  Google Scholar 

  25. Li G, Wang J, Hu W, Zhang Z (2015) Radiation-induced liver injury in three-dimensional conformal radiation therapy (3D-CRT) for postoperative or locoregional recurrent gastric cancer: risk factors and dose limitations. PLoS One 10(8):e0136288

    Article  PubMed  PubMed Central  Google Scholar 

  26. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M (1993) Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 27(1):117–123

    Article  CAS  PubMed  Google Scholar 

  27. Kwek JW, Iyer RB, Dunnington J, Faria S, Silverman PM (2006) Spectrum of imaging findings in the abdomen after radiotherapy. AJR Am J Roentgenol 187(5):1204–1211

    Article  PubMed  Google Scholar 

  28. Munden RF, Erasmus JJ, Smythe WR, Madewell JE, Forster KM, Stevens CW (2005) Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: an unusual CT appearance. AJR Am J Roentgenol 184(4):1091–1095

    Article  PubMed  Google Scholar 

  29. Yamasaki SA, Marn CS, Francis IR, Robertson JM, Lawrence TS (1995) High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis. AJR Am J Roentgenol 165(1):79–84

    Article  CAS  PubMed  Google Scholar 

  30. Willemart S, Nicaise N, Struyven J, van Gansbeke D (2000) Acute radiation-induced hepatic injury: evaluation by triphasic contrast enhanced helical CT. Br J Radiol 73(869):544–546

    Article  CAS  PubMed  Google Scholar 

  31. Unger EC, Lee JK, Weyman PJ (1987) CT and MR imaging of radiation hepatitis. J Comput Assist Tomogr 11(2):264–268

    Article  CAS  PubMed  Google Scholar 

  32. Suto Y, Kato T, Yoshida K, Sugihara S, Kamba M, Ohta YMRI (1996) Findings in radiation-induced hepatic injuries. Yonago Acta Med 39:127–134

    Google Scholar 

  33. Chapman TR, Kumarapeli AR, Nyflot MJ, Bowen SR, Yeung RS, Vesselle HJ, Yeh MM, Apisarnthanarax S (2015) Functional imaging of radiation liver injury in a liver metastasis patient: imaging and pathologic correlation. J Gastrointest Oncol 6(3):E44–E47

    PubMed  PubMed Central  Google Scholar 

  34. Cao Y, Pan C, Balter JM, Platt JF, Francis IR, Knol JA, Normolle D, Ben-Josef E, Ten Haken RK, Lawrence TS (2008) Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys 70(1):154–160

    Article  PubMed  Google Scholar 

  35. Cao Y, Platt JF, Francis IR, Balter JM, Pan C, Normolle D, Ben-Josef E, Haken RK, Lawrence TS (2007) The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model. Med Phys 34(2):604–612

    Article  PubMed  Google Scholar 

  36. Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR, Chen J, Ensminger W, Lawrence TS (2012) A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. Int J Radiat Oncol Biol Phys 83(5):1441–1447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Symon Z, Levi M, Ensminger WD, Smith DE, Lawrence TS (2001 Jun 1) Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model. Int J Radiat Oncol Biol Phys 50(2):473–478

    Article  CAS  PubMed  Google Scholar 

  38. Gençel O, Naziroglu M, Celik O, Yalman K, Bayram D (2010) Selenium and vitamin E modulates radiation-induced liver toxicity in pregnant and nonpregnant rat: effects of colemanite and hematite shielding. Biol Trace Elem Res 135(1–3):253–263

    Article  PubMed  Google Scholar 

  39. Guha C, Kavanagh BD (2011) Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol 21(4):256–263

    Article  PubMed  PubMed Central  Google Scholar 

  40. Bearman SI, Lee JL, Barón AE, McDonald GB (1997) Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 89(5):1501–1506

    CAS  PubMed  Google Scholar 

  41. Palmer KJ, Goa KL (1993) Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs 45(2):259–294

    Article  CAS  PubMed  Google Scholar 

  42. Benimetskaya L, Wu S, Voskresenskiy AM, Echart C, Zhou JF, Shin J, Iacobelli M, Richardson P, Ayyanar K, Stein CA (2008) Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease. Blood 112(10):4343–4352

    Article  CAS  PubMed  Google Scholar 

  43. Li N, Zhang L, Li H, Fang B (2010) Human CD34+ cells mobilized by granulocyte colony-stimulating factor ameliorate radiation-induced liver damage in mice. Stem Cell Res Ther 1(3):22

    Article  PubMed  PubMed Central  Google Scholar 

  44. Guha C, Sharma A, Gupta S, Alfieri A, Gorla GR, Gagandeep S, Sokhi R, Roy-Chowdhury N, Tanaka KE, Vikram B, Roy-Chowdhury J (1999) Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 59(23):5871–5874

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran

    Ainaz Sourati & Ahmad Ameri

  2. Department of Radiotherapy and Oncology, Shohadaye Tajrish Educational Hospital Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran

    Mona Malekzadeh

Authors
  1. Ainaz Sourati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmad Ameri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mona Malekzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Sourati, A., Ameri, A., Malekzadeh, M. (2017). Radiation-Induced Liver Disease. In: Acute Side Effects of Radiation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-55950-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55950-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55949-0

  • Online ISBN: 978-3-319-55950-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation